Stock Market & Financial Investment News

News Breaks October 3, 2012 07:05 EDT GILD Gilead price target raised to $80 from $65 at UBS UBS raised Gilead's price target to reflect its increased market size view of the HCV market. Shares are Buy rated. News For GILD From The Last 14 Days Check below for free stories on GILD the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2013 16:51 EDT GILD Gilead's sofosbuvir gets EMA validation, now under assessment Subscribe for More Information May 20, 2013 07:34 EDT GILD UBS to host a conference Subscribe for More Information May 16, 2013 11:50 EDT GILD Celgene, Gilead lower after new data published at ASCO Subscribe for More Information May 15, 2013 18:32 EDT GILD Gilead announces response data from Phase 2 study of Idelalisib Subscribe for More Information May 13, 2013 09:39 EDT GILD Active equity option families trading Active equity option families trading on open according to Track Data: AAPL C TSLA LVS GILD FSLR Sign up for a free trial to see the rest of the stories you've been missing.